Fig. 5From: Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapiesCopyright © 2019 SpringerIn-vivo anti-tumor activity by mPEG-b-P (Glu-co-Phe) Rg3 NPs. A Fabrication of mPEG-b-P (Glu-co-Phe) Rg3 NPs and their mechanism of preventing colorectal cancer by increasing the expression of caspase-3. B Tumor volume and images of mice treated with NPs. C H&E staining and immunofluorescence images of tumor tissues treated with NPs. D Tumor weight of mice in different groups. Reprinted with the permission from Ref [88].Back to article page